MD HB939 | 2024 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 2 2024 - 25% progression
Action: 2024-02-05 - Hearing 2/22 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 2 2024 - 25% progression
Action: 2024-02-05 - Hearing 2/22 at 1:00 p.m.
Pending: House Health and Government Operations Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring insurers, nonprofit health service plans, and health maintenance organizations to limit the amount a covered individual is required to pay in copayments, coinsurance, and deductibles for a covered prescription epinephrine injector to not more than $60.
Title
Health Insurance - Epinephrine Injectors - Limits on Cost Sharing (Epinephrine Cost Reduction Act of 2024)
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2024-02-05 | House | Hearing 2/22 at 1:00 p.m. |
| 2024-02-02 | House | First Reading Health and Government Operations |
Same As/Similar To
SB989 (Crossfiled) 2024-02-06 - Hearing 3/06 at 1:00 p.m.
Subjects
Drugs
Health
Health - Insurance
Health Insurance
Health Maintenance Organizations
Medical Treatments
Nonprofit Organizations
Prices
Health
Health - Insurance
Health Insurance
Health Maintenance Organizations
Medical Treatments
Nonprofit Organizations
Prices
Code Citations
Maryland State Sources
| Type | Source |
|---|---|
| Summary | https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB0939?ys=2024RS |
| Text | https://mgaleg.maryland.gov/2024RS/bills/hb/hb0939f.pdf |
